Eli Lilly signs Covid-19 drug development deal with Junshi Biosciences

Eli Lilly signs Covid-19 drug development deal with Junshi Biosciences
Eli Lilly has signed an agreement with Chin a-based biopharmaceutical firm Junshi Biosciences to jointly develop therapeutic antibodies to prevent and treat Covid-19👇
👉👉👉👉Read More.